Literature DB >> 27411917

[Lung cancer screening with thoracic X‑ray and CT : Current situation].

O von Stackelberg1,2, H-U Kauczor3,4.   

Abstract

CLINICAL/METHODICAL ISSUE: Attempts at the early detection of lung cancer using imaging methods began as far back as the 1950s. STANDARD RADIOLOGICAL
METHODS: Several studies attempted to demonstrate a reduction of lung cancer mortality by chest radiography screening but all were unsuccessful. METHODICAL INNOVATIONS: Even the first small screening studies using computed tomography (CT) could not demonstrate a reduction in lung cancer-specific mortality until in 2011 the results of the largest randomized controlled low-dose CT screening study in the USA (NLST) were published. The NLST results could show a significant 20 % reduction of lung cancer mortality in elderly and heavy smokers using CT. PERFORMANCE: Confirmation of the NLST results are urgently needed so that the data of the largest European study (NELSON) are eagerly awaited. ACHIEVEMENTS: Pooled with the data from several smaller European studies these results will provide important information and evidence for the establishment of future CT screening programs in Europe. PRACTICAL RECOMMENDATIONS: Randomized controlled trials are the basis of evidence-based medicine; therefore, the positive results of the methodologically very good NLST study cannot be ignored, even if it is the only such study completed so far with highly convincing conclusions. The NLST results clearly demonstrate that positive effects for the health of the population can only be expected if the processes are clearly defined and the quality is assured.

Entities:  

Keywords:  Early detection; Evidence-based medicine; Low-dose computed tomography; Lung cancer mortality; Quality assurance

Mesh:

Year:  2016        PMID: 27411917     DOI: 10.1007/s00117-016-0141-7

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  32 in total

1.  Lung cancer screening white paper: a slippery step forward?

Authors:  Hans-Ulrich Kauczor; Lorenzo Bonomo; Mina Gaga; Kristiaan Nackaerts; Nir Peled; Mathias Prokop; Martine Remy-Jardin; Oyunbileg von Stackelberg; Jean-Paul Sculier
Journal:  Eur Respir J       Date:  2015-11       Impact factor: 16.671

2.  Lung cancer detection. Results of a randomized prospective study in Czechoslovakia.

Authors:  A Kubík; J Polák
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

3.  Results of the two incidence screenings in the National Lung Screening Trial.

Authors:  Denise R Aberle; Sarah DeMello; Christine D Berg; William C Black; Brenda Brewer; Timothy R Church; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; Constantine A Gatsonis; David S Gierada; Amanda Jain; Gordon C Jones; Irene Mahon; Pamela M Marcus; Joshua M Rathmell; JoRean Sicks
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

4.  Cost-effectiveness of CT screening in the National Lung Screening Trial.

Authors:  William C Black; Ilana F Gareen; Samir S Soneji; JoRean D Sicks; Emmett B Keeler; Denise R Aberle; Arash Naeim; Timothy R Church; Gerard A Silvestri; Jeremy Gorelick; Constantine Gatsonis
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

5.  Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

Authors:  Andrea Lopes Pegna; Giulia Picozzi; Mario Mascalchi; Francesca Maria Carozzi; Laura Carrozzi; Camilla Comin; Cheti Spinelli; Fabio Falaschi; Michela Grazzini; Florio Innocenti; Cristina Ronchi; Eugenio Paci
Journal:  Lung Cancer       Date:  2008-08-23       Impact factor: 5.705

6.  The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.

Authors:  Nichole T Tanner; Neeti M Kanodra; Mulugeta Gebregziabher; Elizabeth Payne; Chanita Hughes Halbert; Graham W Warren; Leonard E Egede; Gerard A Silvestri
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

7.  Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.

Authors:  Maurizio Infante; Fabio Romano Lutman; Silvio Cavuto; Giorgio Brambilla; Giuseppe Chiesa; Eliseo Passera; Enzo Angeli; Maurizio Chiarenza; Giuseppe Aranzulla; Umberto Cariboni; Marco Alloisio; Matteo Incarbone; Alberto Testori; Anna Destro; Federico Cappuzzo; Massimo Roncalli; Armando Santoro; Gianluigi Ravasi
Journal:  Lung Cancer       Date:  2007-10-23       Impact factor: 5.705

8.  UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer.

Authors:  D R Baldwin; S W Duffy; N J Wald; R Page; D M Hansell; J K Field
Journal:  Thorax       Date:  2011-02-11       Impact factor: 9.139

9.  ESR/ERS white paper on lung cancer screening.

Authors:  Hans-Ulrich Kauczor; Lorenzo Bonomo; Mina Gaga; Kristiaan Nackaerts; Nir Peled; Mathias Prokop; Martine Remy-Jardin; Oyunbileg von Stackelberg; Jean-Paul Sculier
Journal:  Eur Radiol       Date:  2015-05-01       Impact factor: 5.315

10.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors:  J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal:  Thorax       Date:  2015-12-08       Impact factor: 9.139

View more
  1 in total

Review 1.  [Incidental findings in chest X‑rays].

Authors:  M O Wielpütz; H-U Kauczor; S Weckbach
Journal:  Radiologe       Date:  2017-04       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.